MedTrace Logo

Couple-oriented Prenatal HIV Counseling in Low and Medium HIV Prevalence Countries

NCT01494961 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1943

Last updated 2011-12-19

No results posted yet for this study

Summary

ANRS 12127 Prenahtest is an intervention trial conducted in four countries (Cameroon, Dominican Republic, Georgia and India), where pregnant women are randomized during prenatal care to receive either standard post-test HIV counseling, or an innovative intervention called couple-oriented post-test HIV counseling (COC).

The aim of the COC intervention is to empower women to communicate with her male partner about HIV, and HIV testing in particular, and encourage him to return for HIV testing and/or couple HIV counseling (where both couple members are counseled together).

Prenahtest is the first randomised trial testing a prenatal intervention to increase partner HIV testing.

Conditions

  • Partner HIV Testing
  • Couple HIV Counseling
  • Couple Communication
  • HIV Incidence

Interventions

BEHAVIORAL

Couple-oriented post-test HIV counseling

COC is an individual behavioural intervention, strengthening standard post-test HIV counselling delivered to pregnant women after prenatal HIV testing. COC was based on the assumption that developing women's communication skills and self-efficacy during HIV counselling would enable them to discuss HIV and sexual issues with their partners, and yield tangible effects on partner HIV testing. The structure of the COC intervention was adapted from a WHO PMTCT counselling manual and was described in a COC manual, which was used to train the COC counsellors and could also be used during the counselling session. Tested during the pilot phase of the trial, COC was shown to be feasible and acceptable in the four study sites.

Sponsors & Collaborators

  • Elizabeth Glaser Pediatric AIDS Foundation

    collaborator OTHER

  • French National Agency for Research on AIDS and Viral Hepatitis

    lead OTHER_GOV

Principal Investigators

  • Francois Dabis, MD - PhD · INSERM U897, Institut de Santé Publique Epidémiologie Développement

  • Patrice T Tchendjou, MD - MPH · Centre Pasteur du Cameroon

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2011-08-31
Completion
2011-10-31

Countries

  • Cameroon
  • Dominican Republic
  • Georgia
  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01494961 on ClinicalTrials.gov